Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 126,669 | 110,403 | 115,082 | 103,501 | 94,503 |
| Cost of Goods | 11,261 | 13,567 | 11,324 | 9,946 | 9,114 |
| Gross Profit | 115,408 | 96,836 | 103,758 | 93,555 | 85,389 |
| Operating Expenses | 100,702 | 125,124 | 107,774 | 111,524 | 104,363 |
| Operating Income | 14,967 | -27,721 | -3,692 | -17,023 | -18,860 |
| Interest Expense | 12,512 | 12,436 | 12,827 | 12,986 | 12,492 |
| Other Income | -2,347 | -3,426 | -15,141 | 5,304 | -9,165 |
| Pre-tax Income | 108 | -43,583 | -31,660 | -24,705 | -40,517 |
| Income Tax | 15,805 | 4,836 | 2,183 | -3,128 | 2,715 |
| Net Income Continuous | -15,697 | -48,419 | -33,843 | -21,577 | -43,232 |
| Net Income | $-15,697 | $-48,419 | $-33,843 | $-21,577 | $-43,232 |
| EPS Basic Total Ops | -0.05 | -0.16 | -0.11 | -0.07 | -0.15 |
| EPS Basic Continuous Ops | -0.05 | -0.16 | -0.11 | -0.07 | -0.15 |
| EPS Diluted Total Ops | -0.05 | -0.16 | -0.11 | -0.07 | -0.15 |
| EPS Diluted Continuous Ops | -0.05 | -0.16 | -0.11 | -0.07 | -0.15 |
| EPS Diluted Before Non-Recurring Items | 0.01 | -0.02 | -0.11 | N/A | N/A |
| EBITDA(a) | $17,709 | $-25,036 | $-974 | $-14,074 | $-15,962 |